Obstructive sleep apnea hypopnea syndrome: A proinflammatory disorder

Chinese Medical Journal

Volumn 120, Issue 17, 2007, Pages 1475-1476

  Han, Fang ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATORY DISEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME;

EID: 34848901034     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200709010-00001     Document Type: Editorial

References (9)

1. Wiernsperger N, Nivoit P, Bouskela E. Obstructive sleep apnea and insulin resistance: a role for microcirculation? Clinics 2006; 61: 253-266.
2. Zhang XL, Yin KS, Li C, Jia EZ, Li YC, Gao ZF. Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome. Chin Med J 2007; 120: 1477-1481.
3. Ye J, Liu H, Li Y. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J 2007; 120: 1482-1486.
4. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998; 53: S25-28.
5. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-162.
6. Zhang XL, Yin KS, Mao H, Wang H, Yang Y. Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome. Chin Med J 2004; 117: 1603-1606.
7. Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007; 30: 29-34.
8. Schulz R. The vascular micromilieu in obstructive sleep apnoea. Eur Respir J 2005; 25: 780-782.
9. Alam I, Lewis K, Stephens JW, Baxter JN. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev 2007; 8: 119-127.